Melatonin Agonist for Free-Running Type Sleep Disorder
نویسندگان
چکیده
123 Received April 15, 2014; revised and accepted September 5, 2014. Published online September 23, 2014; doi: 10.1620/tjem.234.123. Correspondence: Yuichi Inoue, M.D., Ph.D., Japan Somnology Center, Neuropsychiatric Research Institute, 1-24-10 Yoyogi, Shibuyaku, Tokyo 151-0053, Japan. e-mail: [email protected] The Melatonin Receptor Agonist Is Effective for Free-Running Type Circadian Rhythm Sleep Disorder: Case Report on Two Sighted Patients
منابع مشابه
Circadian Rhythm Sleep Disorders: Part II, Advanced Sleep Phase Disorder, Delayed Sleep Phase Disorder, Free-Running Disorder, and Irregular Sleep-Wake Rhythm
(Section numbers run consecutively through Parts I and II) 9.0 Introduction 10.0 CRSDs and Molecular Genetics 11.0 Advanced Sleep Phase Disorder (ASPD) 11.1 Diagnostic Issues 11.2 Risk Factors 11.2.1 Age 11.2.2 Gender 11.2.3 Light Exposure 11.3 Assessment Tools 11.3.1 Sleep Logs and Actigraphy 11.3.2 Morningness-Eveningness Questionnaire (MEQ) 11.3.3 Polysomnography (PSG) 11.3.4 Phase Markers 1...
متن کاملNon-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management
Several aspects of human physiology and behavior are dominated by 24-h circadian rhythms with key impacts on health and well-being. These include mainly the sleep-wake cycle, vigilance and performance patterns, and some hormone secretions. The rhythms are generated spontaneously by an internal "pacemaker," the suprachiasmatic nuclei within the anterior hypothalamus. This master clock has, for m...
متن کاملMelatonin agonists for treatment of sleep and depressive disorders
Melatonin the hormone secreted by the pineal gland has been effective in improving sleep both in normal sleepers and insomniacs and has been used successfully in treating sleep and circadian rhythm sleep disorders. The lack of consistency in the reports published by the authors is attributed to the differential bioavailabilty and short half-life of melatonin. Sleep disturbances are also promine...
متن کاملMechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients.
ISSUE Many individuals with total blindness can develop a circadian rhythm disorder-called non-24 sleep wake syndrome-because they cannot detect light to resynchronize their sleep-wake cycles. A new melatonin 1 and melatonin 2 agonist tasimelteon improves sleep in these patients, resetting their circadian sleep-wake clocks.
متن کاملThe Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
Children with autism spectrum disorders (ASD), including autistic disorder, frequently suffer from comorbid sleep problems. An altered melatonin rhythm is considered to underlie the impairment in sleep onset and maintenance in ASD. We report three cases with autistic disorder in whom nocturnal symptoms improved with ramelteon, a selective melatonin receptor agonist. Insomnia and behavior, asses...
متن کامل